Literature DB >> 17466710

Multidrug resistance proteins affect drug transmission across the placenta.

Samuel Parry1, Jian Zhang.   

Abstract

OBJECTIVE: We studied the role of multidrug resistance proteins in regulating transplacental transmission of corticosteroids and protease inhibitors. STUDY
DESIGN: We performed quantitative polymerase chain reaction and FACS analyses to study MDR1 (encodes P-glycoprotein) and MRP-1 expression in extravillous (HTR-8/SVneo) and villous (BeWo) trophoblast cells treated with saquinavir, a multidrug resistance protein substrate. We measured H3-dexamethasone and H3-ritonavir transfer across confluent, syncytialized BeWo cells before and after treatment with agents that inhibit multidrug resistance proteins.
RESULTS: Compared with baseline expression, messenger RNA and protein levels were increased significantly in trophoblast cells after treatment with saquinavir. H3-dexamethasone and H3-ritonavir levels increased in BeWo cells after treatment with anti-P-glycoprotein antibodies or cyclosporine A. Transfer of H3-labeled drugs from the apical (eg, maternal) to basolateral (eg, fetal) side of the syncytialized BeWo cell monolayer was increased significantly when cells were pretreated with anti-P-glycoprotein antibodies.
CONCLUSION: Multidrug resistance proteins regulate drug levels in trophoblast cells and may mediate transmission of therapeutic agents across the placenta.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466710     DOI: 10.1016/j.ajog.2007.02.019

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Nanoparticles can cause DNA damage across a cellular barrier.

Authors:  Gevdeep Bhabra; Aman Sood; Brenton Fisher; Laura Cartwright; Margaret Saunders; William Howard Evans; Annmarie Surprenant; Gloria Lopez-Castejon; Stephen Mann; Sean A Davis; Lauren A Hails; Eileen Ingham; Paul Verkade; Jon Lane; Kate Heesom; Roger Newson; Charles Patrick Case
Journal:  Nat Nanotechnol       Date:  2009-12       Impact factor: 39.213

Review 2.  Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research.

Authors:  T Lewis; J Dinh; J S Leeder
Journal:  Clin Pharmacol Ther       Date:  2015-07-22       Impact factor: 6.875

Review 3.  Drug transporters in the human blood-placental barrier.

Authors:  Kirsi Vähäkangas; Päivi Myllynen
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

4.  Changes in the placental glucocorticoid barrier during rat pregnancy: impact on placental corticosterone levels and regulation by progesterone.

Authors:  Peter J Mark; Sheldon Augustus; Jessica L Lewis; Damien P Hewitt; Brendan J Waddell
Journal:  Biol Reprod       Date:  2009-02-04       Impact factor: 4.285

Review 5.  P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease.

Authors:  Iman Imtiyaz Ahmed Juvale; Azzmer Azzar Abdul Hamid; Khairul Bariyyah Abd Halim; Ahmad Tarmizi Che Has
Journal:  Heliyon       Date:  2022-06-22

6.  Placental HSD2 Expression and Activity Is Unaffected by Maternal Protein Consumption or Gender in C57BL/6 Mice.

Authors:  Mark R Garbrecht; Fred S Lamb
Journal:  ISRN Endocrinol       Date:  2013-05-28

7.  P-Glycoprotein (P-gp)/ABCB1 plays a functional role in extravillous trophoblast (EVT) invasion and is decreased in the pre-eclamptic placenta.

Authors:  Caroline E Dunk; Jane J Pappas; Phetcharawan Lye; Mark Kibschull; Mohsen Javam; Enrrico Bloise; Stephen J Lye; Moshe Szyf; Stephen G Matthews
Journal:  J Cell Mol Med       Date:  2018-09-05       Impact factor: 5.310

8.  Combination of the BeWo b30 placental transport model and the embryonic stem cell test to assess the potential developmental toxicity of silver nanoparticles.

Authors:  Ashraf Abdelkhaliq; Meike van der Zande; Ruud J B Peters; Hans Bouwmeester
Journal:  Part Fibre Toxicol       Date:  2020-03-10       Impact factor: 9.400

9.  P-gp expression inhibition mediates placental glucocorticoid barrier opening and fetal weight loss.

Authors:  Caiyun Ge; Dan Xu; Pengxia Yu; Man Fang; Juanjuan Guo; Dan Xu; Yuan Qiao; Sijia Chen; Yuanzhen Zhang; Hui Wang
Journal:  BMC Med       Date:  2021-12-08       Impact factor: 11.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.